Panacea Biotec Limited — Others, 14-11-2024: Copy of Newspaper Publication

Panacea Biotec Limited has announced a board meeting to approve the financial results for the quarter and half-year ended September 30, 2024. The company's total income for this period stands at ₹382.41 crore, with a net profit before tax of ₹70.48 crore and a net profit after tax of ₹52.13 crore. This positive financial performance may contribute to improved investor sentiment, highlighting potential growth opportunities in the pharmaceutical sector. The meeting signifies the management's commitment to transparent and timely financial reporting, which could enhance shareholder confidence moving forward.